Pfizer settles dispute with workers over closure of plant

Irungattukottai plant was closed in 2019 and 270 workers lost their jobs

Published - October 16, 2020 02:14 am IST - CHENNAI

The Industrial Tribunal, Tamil Nadu, has closed the dispute between pharma giant Pfizer Healthcare India Pvt. Ltd. and a section of its workers, after the parties reached a settlement agreement. The dispute relates to closure of the company’s plant at Irungattukottai and job loss of 270 workers.

In early 2019, Pfizer decided to shut down two of its Indian manufacturing plants — Irungattukottai (Chennai) and Aurangabad (Maharashtra) — due to issues of viability. The manufacturing plants had come under Pfizer’s fold after it acquired Ospira, a provider of injectable drugs and infusion technologies in 2015.

The Podhu Thozhilalar Sangam had raised a dispute before the Deputy Commissioner of Labour, Sriperumbudur, with regard to cessation of employment of 270 workmen. Talks failed and the dispute was referred to the Industrial Tribunal, Tamil Nadu, according to court documents.

After the submission of the report, both parties said they had entered into a settlement and the claims of the members of the petitioner union had been settled, the Industrial Tribunal said.

As per the settlement reached on February 6, Pfizer paid members of the union about ₹4.67 crore. The Industrial Tribunal recorded the settlement and disposed of the case.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.